Form 4: Alphatec COO Sells Shares via 10b5-1 Plan

Alphatec Holdings, Inc.'s Chief Operating Officer, Scott Lish, sold 6,323 shares of common stock for $16.01 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Summary

• Scott Lish, Chief Operating Officer of Alphatec Holdings, Inc. (ATEC), sold 6,323 shares of common stock.
• The transaction occurred on August 21, 2025.
• The shares were sold at a weighted average price of $16.01, with individual transactions ranging from $16.00 to $16.02.
• Following this sale, Scott Lish beneficially owns 658,707 shares of Alphatec common stock.
• The sale was executed under a Rule 10b5-1 trading plan, which was adopted on March 14, 2025.

Sentiment

Score: 5

Explanation: A neutral score. While an insider sale can be perceived negatively, the fact that it's part of a pre-arranged 10b5-1 plan mitigates concerns that it's based on new, negative information. It's a routine liquidity event for an executive.

Positives

• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating it was not based on new, non-public information.

Negatives

• An insider sale, even if pre-planned, can sometimes be perceived negatively by the market as it reduces the insider's direct equity stake.

Future Outlook

No forward-looking statements or guidance are provided.

Industry Context

This Form 4 is a routine insider transaction filing and does not provide broader industry context. Alphatec Holdings operates in the medical device industry, specifically spine surgery.

Comparison to Industry Standards

• This filing is a standard insider transaction report. There are no specific financial results or operational metrics to compare against industry benchmarks.
• Insider sales via 10b5-1 plans are common practice across industries for executives to manage their equity holdings.

Stakeholder Impact

• Shareholders: The sale reduces the COO's direct ownership, which could be interpreted as a slight negative signal, though mitigated by the 10b5-1 plan.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this filing.

Key Dates

Recommendation

The filing details a routine insider stock sale executed under a pre-arranged Rule 10b5-1 trading plan. This type of transaction is typically for personal financial planning and does not inherently signal a change in the company's fundamental outlook or performance. Given the pre-planned nature, it does not provide new information to warrant a 'buy' or 'sell' recommendation based solely on this filing. Investors should 'hold' and consider broader company fundamentals and market conditions.

Keywords

Alphatec Holdings, ATEC, Scott Lish, Insider Trading, Form 4, 10b5-1 Plan, Stock Sale, Chief Operating Officer, Medical Devices, Spine Surgery